Hep C Spread in North America: When and How did it Start?

News
Article

Timing of the rise of hep C in North America is a puzzle. In this Medical News Minute, Dr Bobby Lazzara toplines results of a new study that offer clarity.

 

In this Medical News Minute, developed exclusively for Consultantlive.com, Dr. Bobby Lazzara discusses a study that sought to clarify timing of the initial spread of the hepatitis C virus genotype 1A in North America.

Published in Lancet Infectious Disease, the study results suggest that factors other than historically stigmatized “risky behaviors” were key contributors to the notable rise and prevalence of the disease in specific demographic groups. 

Source: Joy JB, McCloskey RM, Nguyen T, et al. The spread of hepatitis C virus genotype 1a in North America: a retrospective phylogenetic study. Lancet Infect Dis. 2016;16:698-702. doi: 10.1016/S1473-3099(16)00124-9. Epub 2016 Mar 30.

 

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Interview with Kelly Moore, MD, MPH, president, chief executive officer, Immunization Action Coalition
Related Content
COVID-19 Associated with Higher Long-Term Mortality Than Flu or RSV: New Data / Image credit: ©freshidea/AdobeStock

COVID-19 Associated with Higher Long-Term Mortality Than Flu or RSV: New Data

Sydney Jennings
February 3rd 2025
Article

Researchers found that COVID-19 had a higher long-term mortality than influenza and RSV in veterans—underscoring vaccination’s vital role.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

FDA Clears Cobas Liat Assay Panels for Point-of-Care Diagnosis of Sexually Transmitted Infections

FDA Clears Cobas Liat Assay Panels for Point-of-Care Diagnosis of Sexually Transmitted Infections

Patient Care Editorial Staff
January 23rd 2025
Article

These test panels allow clinicians to diagnose multiple STIs from a single specimen, with results available in about 20 minutes.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

FDA Updates RSV Vaccine Labels to Include Guillain-Barré Syndrome Warning / Image credit: ©MargJohnsonVA/AdobeStock

FDA Updates RSV Vaccine Labels to Include Guillain-Barré Syndrome Warning

Sydney Jennings
January 8th 2025
Article

The FDA approved the addition of Guillain-Barré syndrome warnings for Abrysvo and Arexvy, citing postmarketing data suggesting an increased risk.

Bird Flu: First US Death Reported, NIH Updates Risk Assessment

Bird Flu: First US Death Reported, NIH Updates Risk Assessment

John Parkinson;Grace Halsey
January 7th 2025
Article

The first death of an American from the H5N1 virus was reported in Louisiana on Monday, though authorities maintain the risk of widespread infection remains low.

© 2025 MJH Life Sciences

All rights reserved.